Compile Data Set for Download or QSAR
maximum 50k data
Found 128 Enz. Inhib. hit(s) with all data for entry = 9428
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM50357312(IBRUTINIB | PCI-32765 | US10124003, Ref. Ex. Compo...)
Affinity DataIC50:  1.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465786(US10793576, Example 18)
Affinity DataIC50:  1.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465837(US10793576, Example 69)
Affinity DataIC50:  1.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465822(US10793576, Example 54)
Affinity DataIC50:  1.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465821(US10793576, Example 53)
Affinity DataIC50:  1.80nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465816(US10793576, Example 48)
Affinity DataIC50:  2.10nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465823(US10793576, Example 55)
Affinity DataIC50:  2.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465820(US10793576, Example 52)
Affinity DataIC50:  2.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465838(US10793576, Example 70)
Affinity DataIC50:  2.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465779(US10793576, Example 11)
Affinity DataIC50:  2.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465777(US10793576, Example 9)
Affinity DataIC50:  2.80nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465865(US10793576, Example 97)
Affinity DataIC50:  2.80nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465864(US10793576, Example 96)
Affinity DataIC50:  3.10nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465781(US10793576, Example 13)
Affinity DataIC50:  3.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465790(4-(3-((1R,3S,4S)-2-acryloyl-2-azabicyclo[2.2.1]hep...)
Affinity DataIC50:  3.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465861(Preparation of (S)-1-(6-(8-amino-1-(4-phenoxypheny...)
Affinity DataIC50:  3.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465814(US10793576, Example 46)
Affinity DataIC50:  4.20nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465824(US10793576, Example 56)
Affinity DataIC50:  4.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465860(US10793576, Example 92)
Affinity DataIC50:  4.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465894(Preparation of (1 S,4S)-tert-butyl-5-acryloyl-6-(8...)
Affinity DataIC50:  4.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465811(US10793576, Example 43)
Affinity DataIC50:  4.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465772(US10793576, Example 4)
Affinity DataIC50:  4.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465881(Preparation of 4-(8-amino-3-((1S)-2-((E)-4-(dimeth...)
Affinity DataIC50:  4.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465872(US10793576, Example 104)
Affinity DataIC50:  4.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465771(US10793576, Example 3)
Affinity DataIC50:  4.70nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465817(US10793576, Example 49)
Affinity DataIC50:  4.80nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465847(US10793576, Example 79)
Affinity DataIC50:  4.90nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465815(US10793576, Example 47)
Affinity DataIC50:  5.20nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465836(US10793576, Example 68)
Affinity DataIC50:  5.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465810(US10793576, Example 42)
Affinity DataIC50:  5.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465886(Preparation of 4-(3-((1R,2S,4S)-7-acryloyl-7-azabi...)
Affinity DataIC50:  5.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465862(US10793576, Example 94 | US10793576, Example 95)
Affinity DataIC50:  7.20nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465845(US10793576, Example 77)
Affinity DataIC50:  8.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465774(US10793576, Example 6)
Affinity DataIC50:  9.10nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465853(US10793576, Example 85)
Affinity DataIC50:  9.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465784(US10793576, Example 16)
Affinity DataIC50:  9.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465839(US10793576, Example 71)
Affinity DataIC50:  12nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465782(US10793576, Example 14)
Affinity DataIC50:  12.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465830(US10793576, Example 62)
Affinity DataIC50:  13nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465780(US10793576, Example 12)
Affinity DataIC50:  14nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465857(US10793576, Example 89 | US10793576, Example 91)
Affinity DataIC50:  14nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465862(US10793576, Example 94 | US10793576, Example 95)
Affinity DataIC50:  14.3nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465852(US10793576, Example 84)
Affinity DataIC50:  16.3nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465813(US10793576, Example 45)
Affinity DataIC50:  17nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465783(US10793576, Example 15)
Affinity DataIC50:  17.4nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465841(US10793576, Example 73)
Affinity DataIC50:  18nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465873(US10793576, Example 105)
Affinity DataIC50:  18nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465892(Preparation of (S)-3-(3-(5-acryloyl-5-azaspiro[2.4...)
Affinity DataIC50:  18nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465846(US10793576, Example 78)
Affinity DataIC50:  18.4nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465877(US10793576, Example 109)
Affinity DataIC50:  19nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: